Nisa Investment Advisors’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Hold |
0
| – | -$6 | – | 3066 |
|
|
2024
Q3 | – | Hold |
0
| – | -$6 | – | 2957 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2934 |
|
|
2024
Q1 | – | Sell |
-31
| Closed | -$483 | – | 2823 |
|
|
2023
Q4 | $483 | Sell |
31
-3
| -9% | -$47 | ﹤0.01% | 2414 |
|
|
2023
Q3 | $1.66K | Buy |
34
+3
| +10% | +$147 | ﹤0.01% | 2354 |
|
|
2023
Q2 | $2.41K | Sell |
31
-139
| -82% | -$10.8K | ﹤0.01% | 2358 |
|
|
2023
Q1 | $15K | Hold |
170
| – | – | ﹤0.01% | 2085 |
|
|
2022
Q4 | $20K | Sell |
170
-57
| -25% | -$6.71K | ﹤0.01% | 2064 |
|
|
2022
Q3 | $37K | Buy |
227
+57
| +34% | +$9.29K | ﹤0.01% | 1857 |
|
|
2022
Q2 | $15K | Buy |
170
+139
| +448% | +$12.3K | ﹤0.01% | 2120 |
|
|
2022
Q1 | $5K | Buy |
+31
| New | +$5K | ﹤0.01% | 2314 |
|
|
2021
Q4 | – | Sell |
-196
| Closed | -$113 | – | 2332 |
|
|
2021
Q3 | $113 | Buy |
196
+153
| +356% | +$88 | ﹤0.01% | 1643 |
|
|
2021
Q2 | $20 | Buy |
+43
| New | +$20 | ﹤0.01% | 2139 |
|